Monthly Archives - September 2020

Patient-Derived Organoids Transform Precision Medicine

Advances in cell culture techniques don’t just mean more accurate models, but more personal ones. For decades scientists have been trying to figure out how to grow cells, especially diseased ones, directly from patients, not only to better understand the mechanisms at play, but also to determine the best approach to cure or correct the malfunction. Today, scientists can grow human tumors in a variety of designer mice, some with human immune systems. Read more >>
Read more...

Myomo Certified as Medicare Provider

Myomo, Inc., a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that the Centers for Medicare & Medicaid Services under the U.S. Department of Health and Human Services has authorized the Company to be a Medicare Provider. Read more >>
Read more...

Wasabi Featured in 2020 CRN Cloud Partner Program Guide

Wasabi, the hot cloud storage company, today announced that it has been featured in the CRN®, a brand of The Channel Company, 2020 Cloud Partner Program Guide. The annual list identifies industry-leading cloud technology vendors with innovative partner programs that empower and accelerate the growth of solution providers’ cloud initiatives. Read more >>
Read more...

SplitSpot Signs Agreement to Acquire Assets of PlaceMe

SplitSpot, a Boston-based co-living platform, has acquired substantial assets of PlaceMe in a deal recently finalized. With the addition, SplitSpot enhances its position as a co-living leader in Boston, with several hundred rooms on its platform. SplitSpot will immediately transition the operations of a significant amount of the units previously managed by PlaceMe. Read more >>
Read more...

We Need Entrepreneurial Leaders Now More Than Ever

Two years ago, David Zamarin wowed the judges on Shark Tank with a water and stain repellent spray, walking away with $200,000 in investments for his startup Detrapel. When the coronavirus struck, Zamarin applied that same entrepreneurial mindset to a new need, pivoting his companyin a matter of weeks to make hand sanitizer and cleaning products. Read more >>
Read more...

Corbus Pharmaceuticals Announces Topline Results from RESOLVE-1 Phase 3 Study of Lenabasum for Treatment of Systemic Sclerosis

Corbus Pharmaceuticals Holdings, Inc., a clinical-stage drug development company pioneering transformative medicines that target the endocannabinoid system, today announced topline results from the 52-week Phase 3 RESOLVE-1 study of lenabasum in patients with diffuse cutaneous systemic sclerosis (SSc). Read more >>
Read more...